News

2020/05/26

Medivir appoints Yilmaz Mahshid as new CEO

Read more
2020/05/06

FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma

Read more
2020/05/05

Resolutions at the Annual General Meeting in Medivir on 5 May 2020

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.